Archive

Rebel Category: REBEL EM

COVID-19 Acute Lung Injury: A Proposed Model (v1.0) via Farid Jalali, MD

There is a lot we still do not know when it comes to COVID-19 pathophysiology. We are learning every day, and as we navigate the waters of the unknown, there are a few that boldly dare to try and understand ...

Read More
Thoracic and Respiratory

The DIRECT-MT Trial: Are Systemic Lytics Necessary in LVO Treatment?

Background: The publication of the MR CLEAN trial in January 2015 changed the face of ischemic stroke care. This was the first study demonstrating a benefit to endovascular treatment of a specific subset of ischemic stroke patients: those with a ...

Read More
Neurology

COVID-19: Triple Antiviral Therapy & IL-1 Inhibition

Background: Current management of COVID-19 focuses on supportive care as there are yet to be robust, data driven treatments. To date, there has barely been a glimmer of hope based on published evidence, as most studies are either poor quality ...

Read More
Infectious Disease

Steroids in Septic Shock via George Willis, MD

“You’re in the emergency department, you have a patient who EMS has brought in from a nursing home…who’s excited? Right, nobody is. And they are brought in for a chief complaint of altered mental status. So they’re concerned about sepsis. ...

Read More
Infectious Disease

Helmet CPAP vs Venturi Mask in Severe Acute Hypoxemic Respiratory Failure due to Pneumonia

Background: Although Helmet CPAP is not something commonly used in the US, I think its nice to know what other potential options there are to help patients in the midst of a COVID-19 pandemic. Hypoxemic acute respiratory failure (hARF) is a ...

Read More
Thoracic and Respiratory
Showing Slide 1 of 6
rebelSWAG-lightbg
gsep-logo-1

Sponsored